WHAT´S NEW in Spondyloarthritis?

In this section you will be able to identify the new content uploaded regularly . 

 Duration 6:31

Prof. William Tillett

Consultant rheumatologist, royal national hospital for rheumatic diseases senior lecturer, pharmacy and pharmacology, University of Bath, UK

 

" The Importance of addressing musculoskeletal signs & symptoms in psoriatic arthritis "

 

 Duration 5:15

Prof. Eduardo Mysler 

Director of the medical research organization, principal investigator and clinical protocol designer for medical institutions, OMI in Buenos Aires, Argentina 

 

"The Role of JAKs in SpA "

 

 Duration 7:15

Prof. Andrew Ostor

Consultant rheumatologist, Cabrini medical cente, and a Melbourne investigator, Emeritus research unit, Melbourne, Australia

 

"Unmet Needs in Axial SpA & PsA "

 

 Duration 8:05

Prof. Philip Mease

Swedish medical center/ Providence St. Joseph Health and university of Washington, Seattle, Washington

 

"Upadacitinib for Active Psoriatic Arthritis Refractory to Biologics (SELECT-PSA 2)"

 

 Duration 7:21

Prof. Ian Mclnnes

University of Glasgow

 

" Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

(SELECT-PSA 1)"

 

 Duration 7:56

Prof. Desiree Van Der Heijde

Leiden University Medical Center, Leiden, The Netherlands

 

"Efficacy and Safety of Upadacitinib in a randomized, double-blind, placebo-controled,multicenter phase 2/3 clinical study of patients with active ankylosing spondylitis (SELECT-AXIS 1)"

 

 Duration 1:20

Abbvie

SPA in ACTION

 

"Psoriatic Arthritis Disease State"

 

 Duration 1:11

Abbvie

SPA in ACTION

 

"Ankylosing Spondylarthritis Disease State"

 

 Duration 1:44

Abbvie

SPA in ACTION

 

"Exploring the JAK-STAT Pathway"

 

 Duration 3:44

Abbvie

RA EVEREST

 

"RA EVEREST: Striving for the highest level of care"

 

 

For Oman HCPs.

Department of Pharmacovigilance & Drug information.

Directorate General of pharmaceutical affairs and Drug control.

Ministry of Health, Sultanate of Oman

Phone Nos:: 22357687 / 22357686

Fax: 22358489

Email: [email protected]

Website:www.moh.gov.om

 

 

This website is intended for Gulf Healthcare Professionals

AbbVie Biopharmaceuticals GmbH.

 

Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

PO Box:: 118052

OFFICE : +971 4 5506100

FAX: +971 4 5506101

Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

[email protected] or Hotline: 00971564135746

JAKa-BH-00004-MC